Title:
METHOD TO DETERMINE A PREDOMINANT IMMUNE SIGNAL IN A BREAST CANCER MICROENVIRONMENT
Document Type and Number:
WIPO Patent Application WO/2024/015997
Kind Code:
A3
Abstract:
Disclosures herein are directed to methods for classifying and characterizing cancer epithelial cells and analyzing their level of interaction with secondary cell populations in order to identify, modify or otherwise tailor immunotherapy and treatment modalities to a patient. Also disclosed are methods of identifying suitable patient candidates for immunotherapy treatments as well as methods of identifying targets of immunotherapies for the treatment and/or prevention of cancer.
Inventors:
CHAN ISAAC (US)
XU LILY (US)
SAUNDERS KAITLYN (US)
XU LILY (US)
SAUNDERS KAITLYN (US)
Application Number:
PCT/US2023/070269
Publication Date:
April 18, 2024
Filing Date:
July 14, 2023
Export Citation:
Assignee:
UNIV TEXAS (US)
International Classes:
C12Q1/6886; C07K16/30; G16B25/10
Attorney, Agent or Firm:
D'AGOSTIN, Rhiannon I. (US)
Download PDF: